Last reviewed · How we verify
20% mannitol solution, 125 ml, IV infusion in 15 min
20% mannitol solution, 125 ml, IV infusion in 15 min is a Small molecule drug developed by Capital Medical University. It is currently FDA-approved.
At a glance
| Generic name | 20% mannitol solution, 125 ml, IV infusion in 15 min |
|---|---|
| Sponsor | Capital Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 20% mannitol solution, 125 ml, IV infusion in 15 min CI brief — competitive landscape report
- 20% mannitol solution, 125 ml, IV infusion in 15 min updates RSS · CI watch RSS
- Capital Medical University portfolio CI
Frequently asked questions about 20% mannitol solution, 125 ml, IV infusion in 15 min
What is 20% mannitol solution, 125 ml, IV infusion in 15 min?
20% mannitol solution, 125 ml, IV infusion in 15 min is a Small molecule drug developed by Capital Medical University.
Who makes 20% mannitol solution, 125 ml, IV infusion in 15 min?
20% mannitol solution, 125 ml, IV infusion in 15 min is developed and marketed by Capital Medical University (see full Capital Medical University pipeline at /company/capital-medical-university).
What development phase is 20% mannitol solution, 125 ml, IV infusion in 15 min in?
20% mannitol solution, 125 ml, IV infusion in 15 min is FDA-approved (marketed).